Search the Site

 
News and views

Stay informed

Home / News and views
Back
News > News Article

22 August 2022

Important: take part in the OFNC timing survey

 

 

Further to our update of 12 August, the OFNC has now opened its NHS sight test timing survey.

By completing this short survey you will help us demonstrate the time it takes to deliver an NHS funded sight test and support one strand of our negotiating strategy on behalf of all GOS contractors in England.

The sight test has grown in content and complexity as diagnostic equipment has improved and the patient mix has become older and more complex. NHS England (NHSE) and the Department of Health and Social Care (DHSC) collect data on patient episodes for other professions but have not done so for some time for primary eye care. It is therefore important to provide data on the current time taken to deliver an NHS sight test so that they better understand resource requirements for delivering GOS.

The survey will close at midnight on Monday 19 September.

If possible, please also encourage local practice/business owners in your LOC to take part.

If you have any questions about the timing survey, please contact the lead at your membership body:

 

Note for Editors

The Optometric Fees Negotiating Committee (OFNC) is the national negotiating body for eye care in England with the Westminster Parliament, the Department of Health and Social Care, and NHS England-NHS Improvement. It comprises the leaders of the UK representative bodies: ABDO, AOP, FODO and BMA (for OMPs) and works in partnerships with the College of Optometrists and the General Optical Council.

 

Share this page
For more information please contact:
OFNC
OFNC

Subscribe

* indicates required
I confirm I would like to receive the following newsletter:

Press enquiries

Media enquiries should be directed to [email protected] or call 020 7298 5151.

We are happy to put you in touch with our expert policy advisers who can comment on a variety of issues.

You can also follow us on Twitter and LinkedIn.